Evidence map›Paper›PMID 31093875›Full record

ArticleMolecular biology reports2019

Optimized Ki-67 staining in murine cells: a tool to determine cell proliferation.

C Graefe, L Eichhorn, P Wurst, J Kleiner, A Heine, I Panetas, Z Abdulla, A Hoeft, S Frede, C Kurts and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Smart materials in medicine · 2023
    Article
  19. Article
  20. Polycationic peptide RBiochemistry and biophysics reports · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

C GraefeDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
L EichhornDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
P WurstFlow Cytometry Core Facility, Institute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.
J KleinerDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
A HeineDepartment of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany.
I PanetasInstitute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.
Z AbdullaInstitute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.
A HoeftDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
S FredeDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
C KurtsInstitute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.
E EndlKoordinationsstelle Research Infrastructure, University Hospital Bonn, Bonn, Germany.
C K WeisheitDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany. Christina.Weisheit@ukbonn.de.ORCID http://orcid.org/0000-0002-7647-1613

Funding

Bonfor (DE) eAntrag 2014-1-22Bonfor (DE) PSP: O-117.0055
6 · The paper itself

Abstract

The reliable analysis of the cell cycle status has become increasingly relevant for scientific and clinical work, especially for the determination of tumor cell growth. One established method to characterize the proliferation activity of cells is the analysis of the Ki-67 protein. Ki-67 is expressed in the nucleus during the whole cell cycle except for the G0 phase. Several different protocols exist for the examination of the Ki-67 protein in tissue and cell culture, but most of them are defined for human cells. For the analysis of the Ki-67 protein in murine tissue and cell culture there is a variety of protocols existing which recommend different fixation and permeabilization reagents or special kits. In this study, we established a reliable protocol for Ki-67 staining in murine cells and tissue based on PFA fixation, which can be used not only for flow cytometry but also for immunofluorescence microscopy analysis. We tested our protocol successfully with three different Ki-67 anti-mouse antibodies in cell culture, regenerating liver tissue and mouse melanoma tumor to demonstrate the general applicability.

Indexed as

AnimalsCell DivisionCell Line, TumorCell NucleusCell ProliferationFlow CytometryHumansKi-67 AntigenMiceMice, Inbred C57BLMicroscopy, FluorescenceStaining and LabelingTumor Cells, CulturedKi-67 AntigenMki67 protein, mouseCell cycleCell proliferationFlow cytometryHoechst stainingImmunofluorescent microscopyKi-67Melanoma tumorMousePartial hepatectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.